Premium
Belite Bio Inc (BLTE)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial a... Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.96 | -2.02310163352 | 146.31 | 151.405 | 130 | 367839 | 142.21741697 | DR |
| 4 | -13.15 | -8.40255591054 | 156.5 | 158.645 | 130 | 224695 | 143.98018224 | DR |
| 12 | -26.4 | -15.5522827688 | 169.75 | 183.67 | 130 | 169661 | 154.23385106 | DR |
| 26 | -7.65 | -5.06622516556 | 151 | 200 | 130 | 196613 | 161.33145828 | DR |
| 52 | 78.64 | 121.52681193 | 64.71 | 200 | 56.1 | 141948 | 142.24562486 | DR |
| 156 | 126.21 | 736.347724621 | 17.14 | 200 | 11 | 90761 | 95.97575435 | DR |
| 260 | 130.85 | 1046.8 | 12.5 | 200 | 8.8 | 91320 | 74.93138329 | DR |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
